About Straumann Group
Straumann Group is a company based in Basel (Switzerland) founded in 1954. Straumann Group has completed 10 acquisitions, including Artis Bio Tech, Biora and ClearCorrect. Straumann Group offers products and services including Straumann iEXCEL System, Prosthetics, Regenerative Products, and Digital Services. Straumann Group operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Basel, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Institut Straumann Ag
-
Annual Revenue
$2.76 B (USD)9.98as on Dec 31, 2024
-
Net Profit
$426.79 M (USD)57.13as on Dec 31, 2024
-
EBITDA
$806.84 M (USD)2.27as on Dec 31, 2024
-
Latest Funding Round
$15.41 K (USD), Grant
Jan 01, 2020
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Artis Bio Tech
& 9 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Straumann Group
Straumann Group offers a comprehensive portfolio of products and services, including Straumann iEXCEL System, Prosthetics, Regenerative Products, and Digital Services.
Versatile dental implant system for professional use
Solutions for crowns, bridges, and screw-retained components
Products for bone grafts and tissue management in dentistry
Tools for guided surgery and workflow integration
People of Straumann Group
Unlock access to complete
Unlock access to complete
Funding Insights of Straumann Group
Investors in Straumann Group
Straumann Group has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Straumann Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Straumann Group
Straumann Group has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Artis Bio Tech, Biora and ClearCorrect.
Investment portfolio details for Straumann Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Transparent orthodontic aligners are developed for malocclusion treatment.
|
Locked | Locked | 2017 | Locked | |
|
A chain of dental clinics is operated in Germany.
|
Locked | Locked | 2017 | Locked | |
|
Standalone dental clinic
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Straumann Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Straumann Group
Detailed financials for Straumann Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Straumann Group Comparisons
Peer comparison for Straumann Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Straumann Group
Straumann Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Straumann Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Straumann Group
Complete news archive for Straumann Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Straumann Group
Straumann Group was founded in 1954 and raised its 1st funding round 64 years after it was founded.
Straumann Group is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Guillaume Daniellot is the current CEO of Straumann Group.
Annual revenue of Straumann Group is $2.76B as on Dec 31, 2024.
The Straumann Group was founded in 1954 and is headquartered in Basel, Switzerland. Operations focus on the dental sector, where implants at soft tissue and bone levels, CAD-CAM prosthetics, biomaterials, and digital tools for tooth replacement are produced. Additional offerings include intra-oral scanners, guided surgery instruments, bone substitutes, membranes, and soft tissue grafts. In 2022, revenues reached 2.43 billion, with net profit at 0.46 billion.
Straumann Group's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Straumann Group offers Straumann iEXCEL System, Prosthetics, Regenerative Products, and Digital Services.
Straumann Group has made 10 acquisitions, including Artis Bio Tech, Biora, and ClearCorrect.
Straumann Group has 1 investor. Key investors include European Union.